45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches

References

• Abend JR, Joseph AE, Das D, et al. (2009). A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J Gen Virol 90:1238–45.
   PubMed Web of Science ®Google Scholar
• Acott P, Babel N. (2012). BK virus replication following kidney transplant: does the choice of immunosuppressive regimen influence outcomes? Ann Transplant 17:86–99.
   PubMed Web of Science ®Google Scholar
• Agnihotri SP, Wuthrich C, Dang X, et al. (2014). A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient. Ann Neurol 76:140–7.
   PubMed Web of Science ®Google Scholar
• Akazawa Y, Terada Y, Yamane T, et al. (2012). Fatal BK virus pneumonia following stem cell transplantation. Transpl Infect Dis 14:E142–6.
   Google Scholar
• Alstadhaug KB, Croughs T, Henriksen S, et al. (2014). Treatment of progressive multifocal leukoencephalopathy with interleukin 7. JAMA Neurol 71:1030–5.
   PubMed Web of Science ®Google Scholar
• Amend KL, Turnbull B, Foskett N, et al. (2010). Incidence of progressive multifocal leukoencephalopathy in patients without HIV. Neurology 75:1326–32.
   PubMed Web of Science ®Google Scholar
• Antinori A, Ammassari A, Giancola ML, et al. (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol 7:323–8.
   PubMed Web of Science ®Google Scholar
• Antinori A, De Luca A, Ammassari A, et al. (1994). Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. AIDS 8:1022–4.
   PubMed Web of Science ®Google Scholar
• Assetta B, Maginnis MS, Gracia Ahufinger I, et al. (2013). 5-HT2 receptors facilitate JC polyomavirus entry. J Virol 87:13490–8.
   PubMed Web of Science ®Google Scholar
• Balduzzi A, Lucchini G, Hirsch HH, et al. (2011). Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplant 46:987–92.
   PubMed Web of Science ®Google Scholar
• Bauman Y, Nachmani D, Vitenshtein A, et al. (2011). An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9:93–102.
   PubMed Web of Science ®Google Scholar
• Bayliss J, Karasoulos T, McLean CA. (2012). Frequency and large T (LT) sequence of JC polyomavirus DNA in oligodendrocytes, astrocytes and granular cells in non-PML brain. Brain Pathol 22:329–36.
   PubMed Web of Science ®Google Scholar
• Bennett SM, Zhao L, Bosard C, Imperiale MJ. (2015). Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry. Virology 474:110–16.
   PubMed Web of Science ®Google Scholar
• Bernhoff E, Gutteberg TJ, Sandvik K, et al. (2008). Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 8:1413–22.
   PubMed Web of Science ®Google Scholar
• Bernhoff E, Tylden GD, Kjerpeseth LJ, et al. (2010). Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 84:2150–6.
   PubMed Web of Science ®Google Scholar
• Berrios C, Jung J, Primi B, et al. (2015). Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors. J Virol 89:857–62.
   PubMed Web of Science ®Google Scholar
• Bloomgren G, Richman S, Hotermans C, et al. (2012). Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870–80.
   PubMed Web of Science ®Google Scholar
• Bodaghi S, Comoli P, Bösch R, et al. (2009). Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 47:2577–85.
   PubMed Web of Science ®Google Scholar
• Bohl DL, Brennan DC, Ryschkewitsch C, et al. (2008). BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 43:184–9.
   PubMed Web of Science ®Google Scholar
• Bohl DL, Storch GA, Ryschkewitsch C, et al. (2005). Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5:2213–21.
   PubMed Web of Science ®Google Scholar
• Boldorini R, Veggiani C, Barco D, Monga G. (2005). Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med 129:69–73.
   PubMed Web of Science ®Google Scholar
• Borni-Duval C, Caillard S, Olagne J, et al. (2013). Risk factors for BK virus infection in the era of therapeutic drug monitoring. Transplantation 95:1498–505.
   PubMed Web of Science ®Google Scholar
• Bozic C, Richman S, Plavina T, et al. (2011). Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Ann Neurol 70:742–50.
   PubMed Web of Science ®Google Scholar
• Brennan DC, Agha I, Bohl DL, et al. (2005). Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5:582–94.
   PubMed Web of Science ®Google Scholar
• Bressollette-Bodin C, Coste-Burel M, Hourmant M, et al. (2005). A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 5:1926–33.
   PubMed Web of Science ®Google Scholar
• Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. (2009). Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840–9.
   PubMed Web of Science ®Google Scholar
• Broekema NM, Imperiale MJ. (2013). miRNA regulation of BK polyomavirus replication during early infection. Proc Natl Acad Sci U S A 110:8200–5.
   PubMed Web of Science ®Google Scholar
• Carson KR, Focosi D, Major EO, et al. (2009). Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816–24.
   PubMed Web of Science ®Google Scholar
• Casado JL, Corral I, García J, et al. (2014). Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. Eur J Clin Microbiol Infect Dis 33:179–87.
   PubMed Web of Science ®Google Scholar
• Cavanagh JB, Greenbaum D, Marshall AH, Rubinstein LJ. (1959). Cerebral demyelination associated with disorders of the reticuloendothelial system. Lancet 2:524–9.
   PubMed Web of Science ®Google Scholar
• Cesaro S, Hirsch HH, Faraci M, et al. (2009). Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis 49:233–40.
   PubMed Web of Science ®Google Scholar
• Chan JF, Ma MK, Chan GS, et al. (2015). Rapid reduction of viruria and stabilization of allograft function by fusidic acid in a renal transplant recipient with JC virus-associated nephropathy. Infection 43:577–81.
   PubMed Web of Science ®Google Scholar
• Chapagain ML, Nerurkar VR. (2010). Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 202:184–91.
   PubMed Web of Science ®Google Scholar
• Chapagain ML, Sumibcay L, Gurjav U, et al. (2008). Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirol 14:448–54.
   PubMed Web of Science ®Google Scholar
• Chapagain ML, Verma S, Mercier F, et al. (2007). Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364:55–63.
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Kurien SS, Nampoory MR. (2013). Molecular characterization of BK and JC viruses circulating among potential kidney donors in Kuwait. Biomed Res Int 2013:7.
   Web of Science ®Google Scholar
• Chen Y, Trofe J, Gordon J, et al. (2008). BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 42:198–202.
   PubMed Web of Science ®Google Scholar
• Chen Y, Trofe J, Gordon J, et al. (2006). Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80:3495–505.
   PubMed Web of Science ®Google Scholar
• Clausi V, Giannecchini S, Magnani E, et al. (2015). Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. Neurol Neuroimmunol Neuroinflamm 2:e58.
   Google Scholar
• Clifford DB, Nath A, Cinque P, et al. (2013). A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19:351–8.
   PubMed Web of Science ®Google Scholar
• Coelho TR, Almeida L, Lazo PA. (2010). JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? Virol J 7:42.
   PubMed Web of Science ®Google Scholar
• Cubitt C. (2006) Molecular genetics of the BK virus. In: Ahsan N, ed. Polyomaviruses and human diseases. Advances in experimental medicine and biology. New York: Springer, 85–95.
   Google Scholar
• Cui X, Wang JC, Deckhut A, et al. (2004). Chinese strains (Type 7) of JC virus are Afro-Asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A). J Mol Evol 58:568–83.
   PubMed Web of Science ®Google Scholar
• Dang X, Chalkias S, Koralnik IJ. (2015). JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression. J Virol Methods 223:25–9.
   PubMed Web of Science ®Google Scholar
• Das D, Wojno K, Imperiale MJ. (2008). BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol 82:2705–14.
   PubMed Web of Science ®Google Scholar
• De Luca A, Ammassari A, Pezzotti P, et al. (2008). Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22:1759–67.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Cingolani A, et al. (1999). Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28:624–8.
   PubMed Web of Science ®Google Scholar
• DeCaprio JA, Garcea RL. (2013). A cornucopia of human polyomaviruses. Nat Rev Microbiol 11:264–76.
   PubMed Web of Science ®Google Scholar
• Diotti RA, Mancini N, Clementi N, et al. (2014). Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy. Antiviral Res 108:94–103.
   PubMed Web of Science ®Google Scholar
• Du Pasquier RA, Kuroda MJ, Zheng Y, et al. (2004a). A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127:1970–8.
   PubMed Web of Science ®Google Scholar
• Du Pasquier RA, Schmitz JE, Jean-Jacques J, et al. (2004b). Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 78:10206–10.
   PubMed Web of Science ®Google Scholar
• Eash S, Querbes W, Atwood WJ. (2004). Infection of vero cells by BK virus is dependent on caveolae. J Virol 78:11583–90.
   PubMed Web of Science ®Google Scholar
• Egli A, Infanti L, Dumoulin A, et al. (2009). Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837–46.
   PubMed Web of Science ®Google Scholar
• Elphick GF, Querbes W, Jordan JA, et al. (2004). The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380–3.
   PubMed Web of Science ®Google Scholar
• Engsig FN, Hansen AB, Omland LH, et al. (2009). Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J Infect Dis 199:77–83.
   PubMed Web of Science ®Google Scholar
• Erard V, Kim HW, Corey L, et al. (2005). BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 106:1130–2.
   PubMed Web of Science ®Google Scholar
• Feltkamp MC, Kazem S, van der Meijden E, et al. (2013). From Stockholm to Malawi: recent developments in studying human polyomaviruses. J Gen Virol 94:482–96.
   PubMed Web of Science ®Google Scholar
• Ferenczy MW, Marshall LJ, Nelson CD, et al. (2012). Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 25:471–506.
   PubMed Web of Science ®Google Scholar
• Fitzmaurice K, Hurst J, Dring M, et al. (2015). Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut 64:813–19.
   PubMed Web of Science ®Google Scholar
• Focosi D, Kast RE, Maggi F, et al. (2008). 5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease. J Infect Dis 197:328 (author reply 328–9).
   PubMed Web of Science ®Google Scholar
• Frohman EM, Monaco MC, Remington G. et al. (2014). JC virus in cd34+ and cd19+ cells in patients with multiple sclerosis treated with natalizumab. JAMA Neurol 71:596–602.
   PubMed Web of Science ®Google Scholar
• Gardner SD, Field AM, Coleman DV, Hulme B. (1971). New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 297:1253–7.
   Google Scholar
• Gasnault J, de Goër de Herve MG, Michot JM, et al. (2014). Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy. Open Forum Infect Dis 1:ofu074.
   PubMedGoogle Scholar
• Gasparovic ML, Gee GV, Atwood WJ. (2006). JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation. J Virol 80:10858–61.
   PubMed Web of Science ®Google Scholar
• Gheuens S, Bord E, Kesari S, et al. (2011). Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85:7256–63.
   PubMed Web of Science ®Google Scholar
• Gheuens S, Wüthrich C, Koralnik IJ. (2013). Progressive multifocal leukoencephalopathy: why gray and white matter. Annu Rev Pathol 8:189–215.
   PubMed Web of Science ®Google Scholar
• Gois PH, Rivelli GG, Pereira LM, Mazzali M. (2012). Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group. Transplant Proc 44:2348–51.
   PubMed Web of Science ®Google Scholar
• Gorelik L, Reid C, Testa M, et al. (2011). Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis 204:103–14.
   PubMed Web of Science ®Google Scholar
• Gosert R, Kardas P, Major EO, Hirsch HH. (2010). Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 84:10448–56.
   PubMed Web of Science ®Google Scholar
• Gosert R, Rinaldo CH, Funk GA, et al. (2008). Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 205:841–52.
   PubMed Web of Science ®Google Scholar
• Guasch A, Roy-Chaudhury P, Woodle ES, et al. (2010). Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 90:891–7.
   PubMed Web of Science ®Google Scholar
• Hall CD, Dafni U, Simpson D, et al. (1998). Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338:1345–51.
   PubMed Web of Science ®Google Scholar
• Harris KF, Christensen JB, Imperiale MJ. (1996). BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol 70:2378–86.
   PubMed Web of Science ®Google Scholar
• Hayden RT, Gu Z, Liu W, et al. (2015). Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 17:234–41.
   PubMed Web of Science ®Google Scholar
• Hedquist BG, Bratt G, Hammarin AL, et al. (1999). Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology 106:129–32.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Babel N, Comoli P, et al. (2014). European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect 20:74–88.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Brennan DC, Drachenberg CB, et al. (2005). Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyzes and recommendations. Transplantation 79:1277–86.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Knowles W, Dickenmann M, et al. (2002). Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347:488–96.
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Randhawa P. (2009). BK virus in solid organ transplant recipients. Am J Transplant 9:S136–S46.
   Google Scholar
• Hohlfeld SK, Günthard HF, Zeitz J, et al. (2012). Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis. BMJ Case Rep. doi: 10.1136/bcr.03.2011.4036.
   PubMedGoogle Scholar
• Hunt D, Giovannoni G. (2012). Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring. Pract Neurol 12:25–35.
   PubMedGoogle Scholar
• Jelcic I, Combaluzier B, Jelcic I, et al. (2015). Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy. Sci Transl Med 7:306ra150.
   PubMed Web of Science ®Google Scholar
• Jelcic I, Jelcic I, Kempf C, et al. (2016). Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant. Ann Neurol 79:404–18.
   PubMed Web of Science ®Google Scholar
• Jiang M, Abend JR, Tsai B, Imperiale MJ. (2009). Early events during BK virus entry and disassembly. J Virol 83:1350–8.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhao L, Gamez M, Imperiale MJ. (2012). Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection. PLoS Pathog 8:e1002898.
   PubMed Web of Science ®Google Scholar
• Jobes DV, Friedlaender JS, Mgone CS, et al. (2001). New JC virus (JCV) genotypes from Papua New Guinea and Micronesia (Type 8 and Type 2E) and evolutionary analysis of 32 complete JCV genomes. Arch Virol 146:2097–113.
   PubMed Web of Science ®Google Scholar
• Johnston O, Jaswal D, Gill JS, et al. (2010). Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 89:1057–70.
   PubMed Web of Science ®Google Scholar
• Jones DT, Taylor WR, Thornton JM. (1992). The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 8:275–82.
   PubMedGoogle Scholar
• Karalic D, Lazarevic I, Knezevic A, et al. (2014). Distribution of JC virus genotypes among Serbian patients infected with HIV and in healthy donors. J Med Virol 86:411–18.
   PubMed Web of Science ®Google Scholar
• KDIGO. (2009). KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9 (Suppl 3):S1–S155.
   PubMed Web of Science ®Google Scholar
• Keller F, Wiesner S, Bunjes D, et al. (2012). Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation. Ann Transplant 17:52–8.
   PubMed Web of Science ®Google Scholar
• Khalili K, White MK, Sawa H, et al. (2005). The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol 204:1–7.
   PubMed Web of Science ®Google Scholar
• Khanna N, Wolbers M, Mueller NJ, et al. (2009). JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 83:4404–11.
   PubMed Web of Science ®Google Scholar
• Knoll GA, Humar A, Fergusson D, et al. (2014). Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA 312:2106–14.
   PubMed Web of Science ®Google Scholar
• Knowles WA, Pipkin P, Andrews N, et al. (2003). Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71:115–23.
   PubMed Web of Science ®Google Scholar
• Komagome R, Sawa H, Suzuki T, et al. (2002). Oligosaccharides as receptors for JC virus. J Virol 76:12992–3000.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Windrem MS, Zou L, et al. (2014). Human glial chimeric mice reveal astrocytic dependence of JC virus infection. J Clin Invest 124:5323–36.
   PubMed Web of Science ®Google Scholar
• Krisl JC, Taber DJ, Pilch N, et al. (2012). Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol 7:1003–9.
   PubMed Web of Science ®Google Scholar
• Krumbholz M, Meinl I, Kümpfel T, et al. (2008). Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350–4.
   PubMed Web of Science ®Google Scholar
• Kuten SA, Patel SJ, Knight RJ, et al. (2014). Observations on the use of cidofovir for BK virus infection in renal transplantation. Transpl Infect Dis 16:975–83.
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Kang JH, Lee JW, et al. (2013). Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience. Transpl Infect Dis 15:569–74.
   PubMed Web of Science ®Google Scholar
• Lee BT, Gabardi S, Grafals M, et al. (2014). Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol 9:583–9.
   PubMed Web of Science ®Google Scholar
• Leung AY, Chan MT, Yuen KY, et al. (2005). Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 40:528–37.
   PubMed Web of Science ®Google Scholar
• Liacini A, Seamone ME, Muruve DA, Tibbles LA. (2010). Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation 90:1450–7.
   PubMed Web of Science ®Google Scholar
• Lindå H, von Heijne A. (2013). Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy. Front Neurol 4:11.
   PubMed Web of Science ®Google Scholar
• Lindberg RL, Achtnichts L, Hoffmann F, et al. (2008). Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 194:153–164.
   PubMed Web of Science ®Google Scholar
• Liu CK, Wei G, Atwood WJ. (1998). Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol 72:4643–9.
   PubMed Web of Science ®Google Scholar
• Low J, Humes HD, Szczypka M, Imperiale M. (2004). BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323:182–8.
   PubMed Web of Science ®Google Scholar
• Low JA, Magnuson B, Tsai B, Imperiale MJ. (2006). Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80:1361–6.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fry TJ, Gress RE. (2011). Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 11:330–42.
   PubMed Web of Science ®Google Scholar
• Martin-Blondel G, Bauer J, Cuvinciuc V, et al. (2013). In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection. Neurology 81:964–70.
   PubMed Web of Science ®Google Scholar
• Marzocchetti A, Sanguinetti M, Giambenedetto SD, et al. (2007). Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis. J Neurovirol 13:338–46.
   PubMed Web of Science ®Google Scholar
• Marzocchetti A, Tompkins T, Clifford DB, et al. (2009). Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 73:1551–8.
   PubMed Web of Science ®Google Scholar
• Marzocchetti A, Wuthrich C, Tan CS, et al. (2008). Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol 14:455–8.
   PubMed Web of Science ®Google Scholar
• Matucci A, Maggi E, Vultaggio A. (2014). Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects. Front Immunol 5:690.
   PubMed Web of Science ®Google Scholar
• Meneguzzi G, Pignatti PF, Barbanti-Brodano G, Milanesi G. (1978). Minichromosome from BK virus as a template for transcription in vitro. Proc Natl Acad Sci USA 75:1126–30.
   PubMed Web of Science ®Google Scholar
• Miller AN, Glode A, Hogan KR, et al. (2011). Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 17:1176–81.
   PubMed Web of Science ®Google Scholar
• Moenster RP, Jett RA. (2012). Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus. Am J Health Syst Pharm 69:496–8.
   PubMed Web of Science ®Google Scholar
• Monaco MC, Jensen PN, Hou J, et al. (1998). Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72:9918–23.
   PubMed Web of Science ®Google Scholar
• Mori M, Kurata H, Tajima M, Shimada H. (1991). JC virus detection by in situ hybridization in brain tissue from elderly patients. Ann Neurol 29:428–32.
   PubMed Web of Science ®Google Scholar
• Moscarelli L, Caroti L, Antognoli G, et al. (2013). Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience. Clin Transplant 27:546–54.
   PubMed Web of Science ®Google Scholar
• Mueller K, Schachtner T, Sattler A, et al. (2011). BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation 91:100–7.
   PubMed Web of Science ®Google Scholar
• Neff RT, Hurst FP, Falta EM, et al. (2008). Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 86:1474–8.
   PubMed Web of Science ®Google Scholar
• Neu U, Allen SA, Blaum BS, et al. (2013). A structure-guided mutation in the major capsid protein retargets BK polyomavirus. PLoS Pathog 9:e1003688.
   Google Scholar
• Neu U, Maginnis MS, Palma AS, et al. (2010). Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8:309–19.
   PubMed Web of Science ®Google Scholar
• O’Hara BA, Atwood WJ. (2008). Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus. Virus Res 132:97–103.
   PubMed Web of Science ®Google Scholar
• Padgett BL, Walker DL, ZuRhein GM, et al. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257–60.
   PubMed Web of Science ®Google Scholar
• Painter W, Robertson A, Trost LC, et al. (2012). First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother 56:2726–34.
   PubMed Web of Science ®Google Scholar
• Pallet N, Burgard M, Quamouss O, et al. (2010). Cidofovir may be deleterious in BK virus-associated nephropathy. Transplantation 89:1542–4.
   PubMed Web of Science ®Google Scholar
• Papadimitriou JC, Randhawa P, Rinaldo CH, et al. (2016). BK polyomavirus infection and renourinary tumorigenesis. Am J Transplant 16:398–406.
   PubMed Web of Science ®Google Scholar
• Papadopoulou A, Gerdemann U, Katari UL, et al. (2014). Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med 6:242ra83.
   PubMed Web of Science ®Google Scholar
• Papanicolaou GA, Lee YJ, Young JW, et al. (2015). Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation. Am J Kidney Dis 65:780–4.
   PubMed Web of Science ®Google Scholar
• Pastrana DV, Brennan DC, Cuburu N, et al. (2012). Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients. PLoS Pathog 8:e1002650.
   Google Scholar
• Pastrana DV, Ray U, Magaldi TG, et al. (2013). BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism. J Virol 87:10105–13.
   PubMed Web of Science ®Google Scholar
• Patel A, Patel J, Ikwuagwu J. (2010). Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother 65:2489–92.
   PubMed Web of Science ®Google Scholar
• Pavesi A. (2003). African origin of polyomavirus JC and implications for prehistoric human migrations. J Mol Evol 56:564–72.
   PubMed Web of Science ®Google Scholar
• Pavlovic D, Patera AC, Nyberg F, et al. (2015). Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord 8:255–73.
   PubMed Web of Science ®Google Scholar
• Perez-Liz G, Del Valle L, Gentilella A, et al. (2008). Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol 64:379–87.
   PubMed Web of Science ®Google Scholar
• Pho MT, Ashok A, Atwood WJ. (2000). JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 74:2288–92.
   PubMed Web of Science ®Google Scholar
• Plavina T, Subramanyam M, Bloomgren G, et al. (2014). Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76:802–12.
   PubMed Web of Science ®Google Scholar
• Qu Q, Sawa H, Suzuki T, et al. (2004). Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex. J Biol Chem 279:27735–42.
   PubMed Web of Science ®Google Scholar
• Ramos E, Drachenberg CB, Wali R, Hirsch HH. (2009). The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 87:621–30.
   PubMed Web of Science ®Google Scholar
• Randhawa P, Pastrana DV, Zeng G, et al. (2015). Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK. Am J Transplant 15:1014–20.
   PubMed Web of Science ®Google Scholar
• Ray U, Cinque P, Gerevini S, et al. (2015). JC polyomavirus mutants escape antibody-mediated neutralization. Sci Transl Med 7:306ra151.
   PubMed Web of Science ®Google Scholar
• Reid CE, Li H, Sur G, et al. (2011). Sequencing and analysis of JC Virus DNA from natalizumab-treated PML patients. J Infect Dis 204:237–44.
   PubMed Web of Science ®Google Scholar
• Reisman L, Habib S, McClure GB, et al. (2014). Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child. Pediatr Transplant 18:E227–31.
   PubMed Web of Science ®Google Scholar
• Renner FC, Dietrich H, Bulut N, et al. (2013). The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. Transplant Proc 45:1608–10.
   PubMed Web of Science ®Google Scholar
• Rinaldo CH, Gosert R, Bernhoff E, et al. (2010). 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob Agents Chemother 54:4714–22.
   PubMed Web of Science ®Google Scholar
• Ripellino P, Comi C, Mula M, et al. (2011). Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option. BMJ Case Rep. doi: 10.1136/bcr.11.2010.3549.
   PubMedGoogle Scholar
• Rubinstein R, Schoonakker BC, Harley EH. (1991). Recurring theme of changes in the transcriptional control region of BK virus during adaptation to cell culture. J Virol 65:1600–4.
   PubMed Web of Science ®Google Scholar
• Sanchez Fructuoso AI, Calvo N, Perez-Flores I, et al. (2011). Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients. Transpl Infect Dis 13:584–91.
   PubMed Web of Science ®Google Scholar
• Schachtner T, Stein M, Babel N, Reinke P. (2015). The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication. Am J Transplant 15:2159–69.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Adam C, Hirsch HH, et al. (2014). BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 14:1334–45.
   PubMed Web of Science ®Google Scholar
• Schmitt C, Raggub L, Linnenweber-Held S, et al. (2014). Donor origin of BKV replication after kidney transplantation. J Clin Virol 59:120–5.
   PubMed Web of Science ®Google Scholar
• Segarra-Newnham M, Vodolo KM. (2001). Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother 35:741–4.
   PubMed Web of Science ®Google Scholar
• Sener A, House AA, Jevnikar AM, et al. (2006). Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation 81:117–20.
   PubMed Web of Science ®Google Scholar
• Seo GJ, Fink LH, O’Hara B, et al. (2008). Evolutionarily conserved function of a viral microRNA. J Virol 82:9823–8.
   PubMed Web of Science ®Google Scholar
• Sharma AP, Moussa M, Casier S, et al. (2009). Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant 13:123–9.
   PubMed Web of Science ®Google Scholar
• Sharma BN, Li R, Bernhoff E, et al. (2011). Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res 92:115–23.
   PubMed Web of Science ®Google Scholar
• Singh HK, Bubendorf L, Mihatsch MJ, et al. (2006). Urine cytology findings of polyomavirus infections. Adv Exp Med Biol 577:201–12.
   PubMed Web of Science ®Google Scholar
• Sood P, Senanayake S, Sujeet K, et al. (2013). Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study. Transplantation 95:896–902.
   PubMed Web of Science ®Google Scholar
• Sospedra M, Schippling S, Yousef S, et al. (2014). Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1. Clin Infect Dis 59:1588–92.
   PubMed Web of Science ®Google Scholar
• Stroh LJ, Maginnis MS, Blaum BS, et al. (2015). The greater affinity of JC polyomavirus capsid for alpha2,6-linked lactoseries tetrasaccharide c than for other sialylated glycans is a major determinant of infectivity. J Virol 89:6364–75.
   PubMed Web of Science ®Google Scholar
• Sundqvist E, Buck D, Warnke C, et al. (2014). JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants. PLoS Pathog 10:e1004084.
   Google Scholar
• Suzuki T, Orba Y, Makino Y, et al. (2013). Viroporin activity of the JC polyomavirus is regulated by interactions with the adaptor protein complex 3. Proc Natl Acad Sci U S A, 110:18668–73.
   PubMed Web of Science ®Google Scholar
• Tamura K, Stecher G, Peterson D, et al. (2013). MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–9.
   PubMed Web of Science ®Google Scholar
• Tan CS, Dezube BJ, Bhargava P, et al. (2009). Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199:881–8.
   PubMed Web of Science ®Google Scholar
• Tan CS, Koralnik IJ. (2010). Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9:425–37.
   PubMed Web of Science ®Google Scholar
• Tan IL, McArthur JC, Clifford DB, et al. (2011). Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77:1061–7.
   PubMed Web of Science ®Google Scholar
• Teschner S, Gerke P, Geyer M, et al. (2009). Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection. Transplant Proc 41:2533–8.
   PubMed Web of Science ®Google Scholar
• Topalis D, Andrei G, Snoeck R. (2013). The large tumor antigen: a “Swiss Army knife” protein possessing the functions required for the polyomavirus life cycle. Antiviral Res 97:122–36.
   PubMed Web of Science ®Google Scholar
• Trampe AK, Hemmelmann C, Stroet A, et al. (2012). Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology 78:1736–42.
   PubMed Web of Science ®Google Scholar
• Trentalange A, Calcagno A, Ghisetti V, et al. (2016). Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. Antivir Ther. [Epub ahead of print]. doi: 10.3851/IMP3032.
   PubMedGoogle Scholar
• Trowbridge PW, Frisque RJ. (1995). Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 1:195–206.
   PubMed Web of Science ®Google Scholar
• Trydzenskaya H, Sattler A, Müller K, et al. (2011). Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Transplantation 92:1269–77.
   PubMed Web of Science ®Google Scholar
• Uhm J, Hamad N, Michelis FV, et al. (2014). The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD. Bone Marrow Transplant 49:1528–34.
   PubMed Web of Science ®Google Scholar
• van Aalderen MC, Remmerswaal EB, Heutinck KM, et al. (2013). Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults. J Virol 87:10263–72.
   PubMed Web of Science ®Google Scholar
• Van Loy T, Thys K, Ryschkewitsch C, et al. (2015). JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route. J Virol 89:1340–7.
   PubMed Web of Science ®Google Scholar
• Verhalen B, Justice JL, Imperiale MJ, Jiang M. (2015). Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection. J Virol 89:5032–9.
   PubMed Web of Science ®Google Scholar
• Vu D, Shah T, Ansari J, et al. (2015). Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients. Transplant Proc 47:394–8.
   PubMed Web of Science ®Google Scholar
• Waggoner J, Martinu T, Palmer SM. (2009). Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 28:395–8.
   PubMed Web of Science ®Google Scholar
• Warnke C, von Geldern G, Markwerth P, et al. (2014). Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76:792–801.
   PubMed Web of Science ®Google Scholar
• White FA 3rd, Ishaq M, Stoner GL, Frisque RJ. (1992). JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66:5726–34.
   PubMed Web of Science ®Google Scholar
• Williams JW, Javaid B, Kadambi PV, et al. (2005). Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 352:1157–8.
   PubMed Web of Science ®Google Scholar
• Wollebo HS, Woldemichaele B, Khalili K, et al. (2013). Epigenetic regulation of polyomavirus JC. Virol J 10:264.
   PubMed Web of Science ®Google Scholar
• Wu KH, Weng T, Wu HP, et al. (2014). Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study. Pediatr Infect Dis J 33:1193–5.
   PubMed Web of Science ®Google Scholar
• Zanotta N, Delbue S, Rossi T, et al. (2013). Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy. J Med Virol 85:1286–92.
   PubMed Web of Science ®Google Scholar